Emergent BioSolutions Inc. (LON:0IGA)
London · Delayed Price · Currency is GBP · Price in USD 10.58
-0.23 (-2.13%)
Feb 9, 2026, 7:03 PM GMT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
652.10K GBP
Profits / Employee
62.74K GBP
Market Cap
423.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | 2,200 | 366 | 19.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Integrated Diagnostics Holdings | 6,309 |
| Advanced Medical Solutions Group | 1,500 |
| Craneware | 765 |
| Allergy Therapeutics | 584 |
Emergent BioSolutions News
- 20 days ago - HARBOR CAPITAL ADVISORS, INC. Buys 19,684 Shares of Emergent BioSolutions Inc (EBS) - GuruFocus
- 24 days ago - Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading - Benzinga
- 25 days ago - NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading - The Wall Street Journal
- 26 days ago - Emergent BioSolutions Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
- 26 days ago - Emergent BioSolutions Inc. (EBS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - Emergent BioSolutions Inc. (EBS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 26 days ago - Emergent BioSolutions: FDA Approves SNDA For NARCAN Carrying Case - Nasdaq
- 4 weeks ago - Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation - GlobeNewsWire